EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 28 April 2022

Why innovation matters to the research ecosystem: looking at the future of health care

Olivier Laureau (Servier) for POLITICO

The pharmaceutical industry is ready to respond to patients’ rising needs and emerging global health challenges – it needs a conducive legislative and policy framework, and robust research ecosystem that supports innovation.

Recent crises have highlighted the critical need for Europe to secure and strengthen its position as leader in medical innovation. As the European Commission works on the next Pharmaceutical Strategy, we need to ensure Europe has the right environment to bring the next generation of treatments to patients. The challenge for the coming decades is not if medical innovation will happen but where it will happen.

Read more

News

EFPIA Recommendations on a Connected Data System in Europe
28 April 2022

A connected health data ecosystem has the potential to empower more effective and efficient research and development... Read more

Implementing “Good Lay Summary Practice”
22 April 2022

Final report of the GLSP Workshop held on the 14, 15 & 21 February 2022. Read more

Blogs

EU Regulatory Network - New architecture for a new era
28 April 2022 - Sabine Atzor - Emma Du Four

Imagine you built a house. It was not big, but sufficient for what you needed at the time. Over the years, your family... Read more

AMR crisis: Time for new incentives
27 April 2022 - Bruce Altevogt

Why ‘pull’ incentives are vital to tackling antimicrobial resistance (AMR) Read more

World IP Day – Protecting the future of innovation
26 April 2022 - Nathalie Moll

Europe’s intellectual property has delivered advances in medical science and we must not take it for granted Read more

10 things I’ve learned about IP policy
26 April 2022 - Evita van Dam

Intellectual Property is the foundation on which medical innovation is built Read more

Medicines for Society: our ambitions for Dutch patients
19 April 2022

Approximately 11.5 million Dutch people use medicines every day to improve their quality of life, to be able to work... Read more

Events

Towards a new normal: Why boosting cardiovascular health is critical
13 May 2022 (Virtual event)

Opportunities for healthcare systems to build back better for patients in Europe Read more

IHI Kick-off and brokerage event
14 June 2022 (Hotel Le Plaza Brussels & virtual)

Save the date for the first IHI brokerage event Read more

Faster, more equitable access to medicines in Europe

A prescription for change: speeding up access to medicine across Europ
On 25 April 2022 (Financial Times)

On EFPIA's commitment to file in no later than 2 years in all EU member states, this piece features Stefan Oelrich (Bayer),... Read more

Valuing health: novel approaches to financing new medicines
On 25 April 2022 (Financial Times)

This piece features Padraic Ward (Roche) discussing novel pricing mechanisms and equity based tier pricing. Read more

Streamlined EU process promises faster access to breakthrough drugs
On 26 April 2022 (Financial Times)

Nathalie Moll and Mihai Rotaru discuss pan-European health technology assessment. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu